DOI: 10.12890/2025_005953

Stem cell steal after intravenous iron: a case of transient thrombocytopenia in severe iron deficiency anaemia

Authors

  • Canan D. Dirican Department of Internal Medicine, NYMC at St Mary’s General Hospital and St Clare’s Health, Denville, USA
  • Samer Jumean Department of Hematology and Oncology, St Michael’s Medical Center, Newark, USA
  • Hamza Sohail Ansari Department of Internal Medicine, NYMC at St Mary’s General Hospital and St Clare’s Health, Denville, USA
  • Sandhya Rani Reddy Department of Internal Medicine, NYMC at St Mary’s General Hospital and St Clare’s Health, Denville, USA
  • Michael Maroules Department of Hematology and Oncology, St Mary’s General Hospital, Passaic, USA

canandilaydirican@gmail.com

Keywords

Iron deficiency anaemia, intravenous iron, thrombocytopenia, platelet steal phenomenon, stem cell steal effect

Abstract

Background: Iron-deficiency anaemia (IDA) commonly presents with reactive thrombocytosis. A less recognized, paradoxical decline in platelets may occur shortly after iron repletion. This phenomenon is most notably seen with intravenous (IV) formulations and termed the platelet steal effect.
Case report: We describe a 68-year-old man with severe IDA (haemoglobin 6.6 g/dl; mean corpuscular volume 53.4 fl; ferritin 8.7 ng/ml; iron saturation 3.4%) who developed marked thrombocytopenia after initiation of IV iron. The platelet count trended down from 290 ×103/µl on admission to a nadir of 39 ×103/µl by hospital day 5 without bleeding. Other causes of thrombocytopenia were systematically excluded. Iron therapy was continued and transitioned to oral supplementation; platelets stabilized by day 10 and recovered thereafter in parallel with haemoglobin improvement.
Conclusion: Transient thrombocytopenia following iron repletion is likely under-recognized. Awareness of its timing and benign course may prevent unnecessary testing or interruption of definitive IDA therapy.

View the entire article

Downloads

References

  1. Auerbach M, DeLoughery TG, Tirnauer JS. Iron Deficiency in Adults: A Review. JAMA 2025;333:1813-1823. doi: 10.1001/jama.2025.0452
  2. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol 2011;4:177-184. doi: 10.1177/1756283X11398736
  3. Beguin Y. Erythropoietin and platelet production. Haematologica 1999;84:541-547.
  4. Xavier-Ferrucio J, Scanlon V, Li X, Zhang PX, Lozovatsky L, Ayala-Lopez N, et al. Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice. Blood 2019;134(18):1547-1557. https://doi.org/10.1182/blood.2019002039
  5. Evstatiev R, Bukaty A, Jimenez K, et al. Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin. Am J Hematol 2014;89:524-529. doi: 10.1002/ajh.23682
  6. Ganti AK, Shonka NA, Haire WD. Pancytopenia due to iron deficiency worsened by iron infusion: a case report. J Med Case Rep 2007;1:175. doi:10.1186/1752-1947-1-175
  7. Huscenot T, Darnige L, Wagner-Ballon O, Ronchetti AM, Lousteau V, Limal N, et al. Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled study. Ann Hematol 2019;98:2299-2302. doi: 10.1007/s00277-019-03757-0

Published

2025-11-24

How to Cite

1.
Dirican CD, Jumean S, Ansari HS, Reddy SR, Maroules M. Stem cell steal after intravenous iron: a case of transient thrombocytopenia in severe iron deficiency anaemia. EJCRIM [Internet]. 2025 Nov. 24 [cited 2026 Nov. 3];12(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5953

Most read articles by the same author(s)